Peter Clausen Nuo Therapeutics, Inc. (AURX) insider trading activity

AURX Quotes by TradingView

Peter Clausen is CSO/COO of Nuo Therapeutics, Inc.. Currently has a direct ownership of 770,054 shares of AURX, which is worth approximately $1.37 Million. The most recent transaction as insider was on Jul 31, 2025, when has been sold 183,853 shares (Common Stock) at a price of $0.4 per share, resulting in proceeds of $73,541. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 770K
31.36% 3M change
31.36% 12M change
Total Value Held $1.37 Million

PETER CLAUSEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 31 2025
BUY
Exercise of conversion of derivative security
$73,541 $0.4 p/Share
183,853 Added 19.27%
770,054 Common Stock
May 20 2024
BUY
Grant, award, or other acquisition
$11,250 $0.75 p/Share
15,000 Added 2.5%
586,201 Common Stock
Dec 19 2023
BUY
Grant, award, or other acquisition
$10,000 $0.5 p/Share
20,000 Added 3.38%
571,201 Common Stock
Aug 01 2023
BUY
Grant, award, or other acquisition
$50,000 $2.0 p/Share
25,000 Added 4.34%
551,201 Common Stock
Apr 29 2022
BUY
Grant, award, or other acquisition
$25,000 $1.0 p/Share
25,000 Added 4.54%
526,201 Common Stock
PC

Peter Clausen

CSO/COO
Houston, TX

Track Institutional and Insider Activities on AURX

Follow Nuo Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AURX shares.

Notify only if

Insider Trading

Get notified when an Nuo Therapeutics, Inc. insider buys or sells AURX shares.

Notify only if

News

Receive news related to Nuo Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AURX